In breast cancer, the interaction between the fibulin-2 and ADAMTS-12 proteins promotes antitumor effects, but the absence of fibulin-2 evokes the pro-tumor effect of ADAMTS-12 in breast cancer cells (Figure 2) [105]. Here, ADAMTS12 is linked to breast cancer.